Amgen Inc
DUS:AMG
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
A
|
Amgen Inc
DUS:AMG
|
US |
|
Rio Tinto Ltd
OTC:RTNTF
|
AU |
|
I
|
Intuit Inc
LSE:0JCT
|
US |
|
M
|
Masco Corp
F:MSQ
|
US |
|
A
|
Ajinomoto Co Inc
DUS:AJI
|
JP |
|
Panasonic Holdings Corp
TSE:6752
|
JP |
|
Legrand SA
OTC:LGRDY
|
FR |
|
S
|
Samsung Electronics Co Ltd
KRX:005935
|
KR |
|
A
|
Amtech Systems Inc
SWB:AS3
|
US |
|
Relx PLC
LSE:REL
|
UK |
|
D
|
Devon Energy Corp
F:DY6
|
US |
|
Hermes International SCA
PAR:RMS
|
FR |
|
UPM-Kymmene Oyj
F:RPL0
|
FI |
|
D
|
DTE Energy Co
DUS:DGY
|
US |
|
L
|
Lenovo Group Ltd
SWB:LHL1
|
CN |
|
S
|
Santam Ltd
JSE:SNT
|
ZA |
|
Reservoir Media Inc
NASDAQ:RSVR
|
US |
|
F
|
Fujitsu Ltd
DUS:FUJ1
|
JP |
|
E
|
Equifax Inc
XMUN:EFX
|
US |
Bankruptcy Probability
Amgen Inc's probability of bankruptcy is Hidden . The solvency score is Hidden .
We take all the information about a company's solvency, such as how easily it can pay interest on outstanding debt, how much cash it has, the amount of debt, and more, and use it to estimate the probability of bankruptcy.
Solvency Ratios
Solvency Ratios Comparison
Amgen Inc Competitors
| Country | Company | Market Cap | D/E | D/A |
Interest Coverage |
Altman Z-Score |
Quick Ratio |
Current Ratio |
Cash Ratio |
||
|---|---|---|---|---|---|---|---|---|---|---|---|
| US |
|
Amgen Inc
NASDAQ:AMGN
|
219.7B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Eli Lilly and Co
NYSE:LLY
|
1.1T USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
AbbVie Inc
NYSE:ABBV
|
468.4B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| CH |
|
Roche Holding AG
OTC:RHHBF
|
356.4B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| CH |
|
Novartis AG
SIX:NOVN
|
226.1B CHF |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Gilead Sciences, Inc
NASDAQ:GILD
|
187.9B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| DK |
|
Novo Nordisk A/S
CSE:NOVO B
|
1.1T DKK |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
|
82.9B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| AU |
|
CSL Ltd
ASX:CSL
|
85.8B AUD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
|
130.8B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Moderna Inc
NASDAQ:MRNA
|
72.7B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Amgen Inc's probability of bankruptcy is Hidden .
The probability of bankruptcy is estimated using credit risk models that assess financial health, debt levels, interest coverage, and other solvency indicators.
As of the latest report, Amgen Inc has total debt of 51.9B USD. This includes both short-term (0 USD) and long-term (51.9B USD) debt.
You can find a full breakdown on its Balance Sheet.